Maven Securities’s Immune Design Corp. IMDZ Stock Holding History

Maven Securities’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30,000	Closed	-$175K	–	115
2019 Q1	$175K	Buy	+30,000	New	+$102K	0.16%	59

Maven Securities's IMDZ Position: Q2 2019 in Review

Maven Securities sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 30,000 shares — an estimated $175K sold.

Maven Securities first reported a position in IMDZ in Q1 2019 and held it in 1 quarter. The position peaked at $175K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Maven Securities reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Maven Securities sold 30,000 Immune Design Corp. shares in Q2 2019, an estimated $175K.
Maven Securities first reported a position in Immune Design Corp. in Q1 2019 and held it in 1 quarter.
Maven Securities's Immune Design Corp. position peaked at $175K in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Maven Securities's 13F filing for Q2 2019, filed 13 Aug 2019.